CLINICAL_TRIALS
trial_result
· 2024-04-03
Clinical Trial Update: Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes [Phase 3]
Summary
A Phase 3 trial comparing three daily doses of oral semaglutide in adults with Type 2 diabetes has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2024-04-03